These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1318984)
1. [Experience with the combined treatment of recurrent herpes using larifan and a herpetic vaccine]. Potekaev NS; Nosik NN; Samgin MA; Kudratullaev KN; Lavrukhina LA Klin Med (Mosk); 1992 Jan; 70(1):67-70. PubMed ID: 1318984 [TBL] [Abstract][Full Text] [Related]
2. [Use of vaccine interferonogens for treating dermato-neurological syndromes of herpetic etiology]. Mikhaĭlenko AA Tr Inst Im Pastera; 1985; 62():128-30. PubMed ID: 3035754 [No Abstract] [Full Text] [Related]
3. [Current aspects of the problem of specific therapy for herpetic lesions of the central nervous system]. Votiakov VI; Kolomiets AG Vestn Akad Med Nauk SSSR; 1988; (5):3-12. PubMed ID: 2845678 [No Abstract] [Full Text] [Related]
4. [Efficacy of herpetic vaccine, larifan, myelopid and their combinations during herpesvirus infection in irradiated animals]. Alimbarova LM; Barinskiĭ IF Vopr Virusol; 1996; 41(6):270-4. PubMed ID: 8999686 [TBL] [Abstract][Full Text] [Related]
5. [Herpetic pathology and current methods of treating herpetic lesions]. Zhdanov VM; Barinskiĭ IF; Galegov GA; Ershov FI Sov Med; 1983; (10):65-9. PubMed ID: 6362030 [No Abstract] [Full Text] [Related]
6. [Vaccine and poludan in experimental and clinical herpes simplex]. Semenova TB; Selezneva AIu; Fadeeva LL; Barinskiĭ IF Vestn Dermatol Venerol; 1984 Nov; (11):24-7. PubMed ID: 6099018 [No Abstract] [Full Text] [Related]
7. [Herpes simplex infections]. Kimmig W Z Hautkr; 1989 Apr; 64(4):266-8, 271. PubMed ID: 2544060 [TBL] [Abstract][Full Text] [Related]
8. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine]. Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of recurrent herpes labialis using a herpes simplex Type-I subunit vaccine. A prospective randomized double-blind multicenter study]. Altmeyer P; Wehrenberg O; Holzmann H; Paul E; Kimmig WK; Wassilew SW; Petres J; Korger G Hautarzt; 1991 Dec; 42(12):759-63. PubMed ID: 1662671 [TBL] [Abstract][Full Text] [Related]
14. Immunologic and antiviral therapy in herpetic keratitis. Topciu V; Chercotă G; Mihăilescu R; Dressler S Roum Arch Microbiol Immunol; 1992; 51(4):233-7. PubMed ID: 1304828 [TBL] [Abstract][Full Text] [Related]
15. [The new interferon inducer Aktipol in the treatment of herpetic keratitis]. Akberova SI; Musaev Galbinur PI Vestn Oftalmol; 2000; 116(2):16-8. PubMed ID: 11055216 [TBL] [Abstract][Full Text] [Related]
16. [Indices of lymphocyte functional activity in patients with recurrent cutaneous-genital herpes during treatment with a herpes vaccine]. Karpovich LG; Blokha VV; Kalashnikova TV; Bychkova AA; Semenova TB Vopr Virusol; 1986; 31(2):200-5. PubMed ID: 3014750 [TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus: benefit versus risk factors in immunization. zur Hausen H Dev Biol Stand; 1979; 43():373-9. PubMed ID: 230113 [TBL] [Abstract][Full Text] [Related]
18. [The combined treatment of recurrent forms of herpetic keratitis]. Vin'kova GA Oftalmol Zh; 1989; (4):221-4. PubMed ID: 2797696 [TBL] [Abstract][Full Text] [Related]
19. [Current therapy of recurrent herpes]. Potekaev NS; Samgin MA; Barinskii IF Klin Med (Mosk); 1982 Dec; 60(12):78-81. PubMed ID: 6298499 [No Abstract] [Full Text] [Related]
20. [Therapy of recurrent Herpes simplex]. Söltz-Szöts J Z Haut Geschlechtskr; 1971 Apr; 46(8):267-72. PubMed ID: 4324186 [No Abstract] [Full Text] [Related] [Next] [New Search]